Joe Horrigan (Neuren’s Vice President, Clinical Development and Medical Affairs) has joined AMO Pharma as Chief Medical Officer. I assume this means Joe has left Neuren, and I am hoping it is because he has seen the writing on the wall…that Neuren will be acquired within the next 6 months so he might as well lock in a gig somewhere else.
http://www.prnewswire.com/news-rele...harma-as-chief-medical-officer-300252278.html
Joe Horrigan (Neuren’s Vice President, Clinical Development and...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.08 |
Change
-0.640(3.09%) |
Mkt cap ! $2.570B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $20.02 | $951.6K | 47.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 451 | $20.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.10 | 2039 | 8 |
View Market Depth
| Last trade - 11.02am 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |